JP2002537232A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002537232A5 JP2002537232A5 JP2000599251A JP2000599251A JP2002537232A5 JP 2002537232 A5 JP2002537232 A5 JP 2002537232A5 JP 2000599251 A JP2000599251 A JP 2000599251A JP 2000599251 A JP2000599251 A JP 2000599251A JP 2002537232 A5 JP2002537232 A5 JP 2002537232A5
- Authority
- JP
- Japan
- Prior art keywords
- deoxypeganine
- use according
- deoxypeganin
- proportion
- calculated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WUFQLZTXIWKION-UHFFFAOYSA-N Deoxypeganine Chemical compound C1C2=CC=CC=C2N=C2N1CCC2 WUFQLZTXIWKION-UHFFFAOYSA-N 0.000 description 8
- VARHXCYGZKSOOO-UHFFFAOYSA-N Deoxyvasicinone Natural products C1=CC=C2C(=O)N(CCC3)C3=NC2=C1 VARHXCYGZKSOOO-UHFFFAOYSA-N 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 206010057852 Nicotine dependence Diseases 0.000 description 1
- 208000025569 Tobacco Use disease Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19906979.4 | 1999-02-19 | ||
| DE19906979A DE19906979B4 (de) | 1999-02-19 | 1999-02-19 | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
| PCT/EP2000/000975 WO2000048445A2 (de) | 1999-02-19 | 2000-02-08 | Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002537232A JP2002537232A (ja) | 2002-11-05 |
| JP2002537232A5 true JP2002537232A5 (enExample) | 2006-01-05 |
| JP4287596B2 JP4287596B2 (ja) | 2009-07-01 |
Family
ID=7898025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000599251A Expired - Fee Related JP4287596B2 (ja) | 1999-02-19 | 2000-02-08 | ニコチン依存症の治療のためのデオキシペガニン含有医薬組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6548510B1 (enExample) |
| EP (1) | EP1150681B1 (enExample) |
| JP (1) | JP4287596B2 (enExample) |
| KR (1) | KR100681631B1 (enExample) |
| AR (1) | AR022621A1 (enExample) |
| AT (1) | ATE314850T1 (enExample) |
| AU (1) | AU2670600A (enExample) |
| DE (2) | DE19906979B4 (enExample) |
| DK (1) | DK1150681T3 (enExample) |
| ES (1) | ES2255977T3 (enExample) |
| PT (1) | PT1150681E (enExample) |
| WO (1) | WO2000048445A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10119863A1 (de) * | 2001-04-24 | 2002-11-07 | Hf Arzneimittelforsch Gmbh | Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen |
| DE10129265A1 (de) * | 2001-06-18 | 2003-01-02 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie |
| DE10134038A1 (de) * | 2001-07-12 | 2003-02-06 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit |
| DE10163667B4 (de) * | 2001-12-21 | 2006-10-26 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung der klinischen Depression |
| DE10304141B4 (de) | 2003-02-03 | 2006-03-09 | Hf Arzneimittelforschung Gmbh | Verfahren zur Herstellung von Chinazolin-Alkaloiden |
| DE10354894A1 (de) * | 2003-11-24 | 2005-07-07 | Hf Arzneimittelforschung Gmbh | Orale Formulierungen des Desoxypeganins und deren Anwendungen |
| DE10354893B4 (de) * | 2003-11-24 | 2011-03-10 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen |
| EP1981518B1 (en) * | 2006-07-11 | 2013-05-22 | Adnan Jathlan Al-Rehaily | Peganine isolated from anisotes trisulcus l. as a smoking deterrent and anorxigenic agent |
| RU2573293C2 (ru) | 2010-03-26 | 2016-01-20 | Филип Моррис Продактс С.А. | Ингибирование раздражающих ощущений при потреблении некурительных табачных продуктов |
| US8952038B2 (en) | 2010-03-26 | 2015-02-10 | Philip Morris Usa Inc. | Inhibition of undesired sensory effects by the compound camphor |
| US10335378B2 (en) | 2013-03-15 | 2019-07-02 | Altria Client Services Llc | Inhibition of central nervous system effects from smoking and sensory effects from smoking |
| CN104382964B (zh) * | 2014-10-27 | 2017-07-28 | 上海中医药大学 | 一种由骆驼蓬草制备骆驼蓬草总生物碱提取物和骆驼蓬草总黄酮提取物的方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3797494A (en) | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
| US3760805A (en) | 1971-01-13 | 1973-09-25 | Alza Corp | Osmotic dispenser with collapsible supply container |
| US3742951A (en) | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
| US3996934A (en) | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
| SU605614A1 (ru) * | 1971-10-20 | 1978-05-05 | Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср | Антихолинэстеразное средство |
| US3987790A (en) | 1975-10-01 | 1976-10-26 | Alza Corporation | Osmotically driven fluid dispenser |
| US4031894A (en) | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
| US4137300A (en) | 1976-08-20 | 1979-01-30 | Ciba-Geigy Corporation | Sustained action dosage forms |
| DE3315272C2 (de) | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
| US4597961A (en) | 1985-01-23 | 1986-07-01 | Etscorn Frank T | Transcutaneous application of nicotine |
| DE3629304A1 (de) | 1986-08-28 | 1988-03-24 | Lohmann Gmbh & Co Kg | Transdermales therapeutisches system, seine verwendung und verfahren zu seiner herstellung |
| DE3843239C1 (enExample) | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
| DE19906977C1 (de) * | 1999-02-19 | 2000-06-15 | Lohmann Therapie Syst Lts | Desoxypeganin-TTS und seine Verwendung |
| DE19906975B4 (de) * | 1999-02-19 | 2004-04-15 | Lts Lohmann Therapie-Systeme Ag | Arzneiform zur Behandlung von Alzheimer'scher Demenz |
| DE19906974C2 (de) * | 1999-02-19 | 2003-10-09 | Lohmann Therapie Syst Lts | Verwendung von Desoxypeganin zur Behandlung des Alkoholismus |
-
1999
- 1999-02-19 DE DE19906979A patent/DE19906979B4/de not_active Expired - Fee Related
-
2000
- 2000-02-08 AT AT00905035T patent/ATE314850T1/de not_active IP Right Cessation
- 2000-02-08 JP JP2000599251A patent/JP4287596B2/ja not_active Expired - Fee Related
- 2000-02-08 KR KR1020017010491A patent/KR100681631B1/ko not_active Expired - Fee Related
- 2000-02-08 EP EP00905035A patent/EP1150681B1/de not_active Expired - Lifetime
- 2000-02-08 WO PCT/EP2000/000975 patent/WO2000048445A2/de not_active Ceased
- 2000-02-08 ES ES00905035T patent/ES2255977T3/es not_active Expired - Lifetime
- 2000-02-08 DE DE50012014T patent/DE50012014D1/de not_active Expired - Fee Related
- 2000-02-08 DK DK00905035T patent/DK1150681T3/da active
- 2000-02-08 PT PT00905035T patent/PT1150681E/pt unknown
- 2000-02-08 AU AU26706/00A patent/AU2670600A/en not_active Abandoned
- 2000-02-08 US US09/889,650 patent/US6548510B1/en not_active Expired - Fee Related
- 2000-02-17 AR ARP000100678A patent/AR022621A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005500357A5 (enExample) | ||
| JP2004538303A5 (enExample) | ||
| WO2005011656A3 (en) | Pyridyl derivatives and their use as therapeutic agents | |
| JP2004519488A5 (enExample) | ||
| WO2005011654A3 (en) | Pyridyl derivatives and their use as therapeutic agents | |
| JP2003520232A5 (enExample) | ||
| WO2005011653A3 (en) | Pyridazine derivatives and their use as therapeutic agents | |
| JP2002537232A5 (enExample) | ||
| HRP20030951B1 (hr) | Formulacije jednodnevnih doza oksikodona | |
| JP2002528502A5 (enExample) | ||
| NO20022442L (no) | Legemidler for sykdommer i forbindelse med reduksjon i benmasse | |
| JP2002524415A5 (enExample) | ||
| MY125099A (en) | Comminuted form of (s)-2-ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) penyl] propanoic acid | |
| JP2000159790A5 (enExample) | ||
| JP2004537500A5 (enExample) | ||
| JP2003521505A5 (enExample) | ||
| JP2002522501A5 (enExample) | ||
| SE0102440D0 (sv) | New compound | |
| JP2003508467A5 (enExample) | ||
| WO2002000166A3 (en) | New compounds useful as antibacterial agents | |
| JP2003503453A5 (ja) | ガバペンチンおよびプレガバリンを含む相乗作用組成物 | |
| JP2002114686A5 (enExample) | ||
| JP2002537246A5 (enExample) | ||
| MXPA01007210A (es) | Agente para el tratamiento de enfermedad de parkinson que comprende un agente que mejora la funcion del astrocito como ingrediente activo. | |
| WO2002009717A1 (en) | Erectile dysfunction remedies containing prostaglandin derivatives as the active ingredient |